Michael McCaul sold NBIX on November 19, 2024 | PolitAlpha
Michael McCaul sold NBIX (Neurocrine Biosciences Inc) on Nov 19, 2024 with an estimated value between $15,000 and $50,000. This trade was filed under spouse. The stock is currently up 10.5% from the trade price.